Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hodgkin Disease 41Lymphoma 16Urinary Bladder Neoplasms 7Melanoma 6Prostatic Neoplasms 3Neoplasms 3Leukemia 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Skin Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Central Nervous System Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Astrocytoma 2Urothelial Carcinoma of the Bladder 1Urethral Neoplasms 1Ureteral Neoplasms 1Teratoma 1Survival Without Progression 1Seminoma 1Rhabdoid Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pathologic Complete Response 1Oligodendroglioma 1Neurofibromatosis 1 1

Interventions

Carboplatin 5pembrolizumab 4Trastuzumab 4Oxaliplatin 4Fluorouracil 4Cyclophosphamide 4Radiotherapy 3Paclitaxel 3Endoscopy 3Docetaxel 3Cytarabine 3Chemoradiotherapy 3Capecitabine 3toripalimab 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Observation 2Neoadjuvant Therapy 2Metformin 2Magnetic Resonance Imaging 2Leucovorin 2Irinotecan 2Immunotherapy 2Immune Checkpoint Inhibitors 2Epirubicin 2Drug Therapy 2Doxorubicin 2Cisplatin 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × Vinblastine × Clear all
NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Ottawa Hospital Research Institute

Phase 2 Unknown
90 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡